{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T04:01:41Z","timestamp":1793678501085,"version":"4.5.1"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004728","name":"VIT University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004728","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.cca.2020.07.032","type":"journal-article","created":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T01:41:04Z","timestamp":1594950064000},"page":"244-251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Role of TGF-\u03b2 signalling in PCOS associated focal segmental glomerulosclerosis"],"prefix":"10.1016","volume":"510","author":[{"given":"Monica","family":"Bhati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogamaya","family":"D. Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaviyarasi","family":"Renu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balachandar","family":"Vellingiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Padma","family":"Thiagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4370-8776","authenticated-orcid":false,"given":"Aditi","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rituraj","family":"Chakraborty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haritha","family":"Myakala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abilash","family":"Valsala Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2020.07.032_b0005","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.beem.2011.08.001","article-title":"Best Practice & Research Clinical Endocrinology & Metabolism Endocrine disorders & female infertility","volume":"25","author":"Unuane","year":"2011","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2020.07.032_b0010","doi-asserted-by":"crossref","unstructured":"W. Liao, D. Ph, A.C. Roy, D. Ph, C. Chan, A new molecular variant of luteinizing hormone associated with female infertility, 69 (1998) 102\u2013106..","DOI":"10.1016\/S0015-0282(97)00445-7"},{"key":"10.1016\/j.cca.2020.07.032_b0015","unstructured":"S. Sadrefozalayi, F. Farokhi, Effect of the aqueous extract of Foeniculum vulgare (fennel) on the kidney in experimental PCOS female rats, 4 (2014) 110\u2013117."},{"key":"10.1016\/j.cca.2020.07.032_b0020","doi-asserted-by":"crossref","unstructured":"ESHRE\/ASRM. ESHRE\/ASRM Rotterdam Consensus Meeting Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)., Hum. Reprod. 19 (2004) 41e47.","DOI":"10.1093\/humrep\/deh098"},{"key":"10.1016\/j.cca.2020.07.032_b0025","doi-asserted-by":"crossref","unstructured":"ESHRE\/ASRM. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome., Fertil. Steril. 81 (2004) 19e25.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"key":"10.1016\/j.cca.2020.07.032_b0030","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/humrep\/deh207","article-title":"Polycystic ovary syndrome in adolescence - A therapeutic conundrum","volume":"19","author":"Homburg","year":"2004","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.cca.2020.07.032_b0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1749-6632.2010.05648.x","article-title":"Polycystic ovary syndrome in adolescence","volume":"1205","author":"Bruni","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.cca.2020.07.032_b0040","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.fertnstert.2013.04.001","article-title":"Prevalence of polycystic ovary syndrome in adolescents","volume":"100","author":"Christensen","year":"2013","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cca.2020.07.032_b0045","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.ecl.2005.04.005","article-title":"Polycystic ovary syndrome in adolescence","volume":"34","author":"Buggs","year":"2005","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"10.1016\/j.cca.2020.07.032_b0050","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4103\/2230-8210.131162","article-title":"A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India","volume":"18","author":"Joshi","year":"2014","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2020.07.032_b0055","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1016\/j.fertnstert.2006.04.015","article-title":"Clinical expression of polycystic ovary syndrome in adolescent girls","volume":"86","author":"Sultan","year":"2006","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.cca.2020.07.032_b0060","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13461","article-title":"Consequences of advanced aging on renal function in chronic hyperandrogenemic female rat model: implications for aging women with polycystic ovary syndrome","author":"Patil","year":"2017","journal-title":"Physiol Rep"},{"key":"10.1016\/j.cca.2020.07.032_b0065","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00467-006-0357-2","article-title":"Pathophysiology of focal segmental glomerulosclerosis","volume":"22","author":"Reidy","year":"2007","journal-title":"Pediatr. Nephrol."},{"key":"10.1016\/j.cca.2020.07.032_b0070","doi-asserted-by":"crossref","unstructured":"R.S. Newfield, I. Koren, L. Slezak, G. Boner, E. Rosenmann, K. Bloch, P. Vardi, Diabetes & Metabolic Syndrome\u00a0: Clinical Research & Reviews Early onset of proteinuria and focal segmental glomerulosclerosis in obese , hyperinsulinemic adolescents developing metabolic syndrome, 3 (2009) 169\u2013174. https:\/\/doi.org\/10.1016\/j.dsx.2009.02.001.","DOI":"10.1016\/j.dsx.2009.02.001"},{"key":"10.1016\/j.cca.2020.07.032_b0075","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-14-74","article-title":"Pathophysiology and treatment of focal segmental glomerulosclerosis: The role of animal models","volume":"14","author":"De Mik","year":"2013","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.cca.2020.07.032_b0080","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1177\/014107680109400510","article-title":"Partial lipodystrophy, polycystic ovary syndrome and proteinuria: A common link to insulin resistance?","volume":"94","author":"Blackwell","year":"2001","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.cca.2020.07.032_b0085","doi-asserted-by":"crossref","unstructured":"Activation of the TGF- NL \/ Smad signaling pathway in focal segmental glomerulosclerosis, 64 (2003) 1715\u20131721. https:\/\/doi.org\/10.1046\/j.1523-1755.2003.00288.x.","DOI":"10.1046\/j.1523-1755.2003.00288.x"},{"key":"10.1016\/j.cca.2020.07.032_b0090","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0895-7061(97)00075-7","article-title":"Mechanisms of abnormal renal sodium handling in obesity hypertension*1","volume":"10","author":"Hall","year":"1997","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cca.2020.07.032_b0095","first-page":"71","author":"Monit","year":"2007","journal-title":"So Ly L"},{"key":"10.1016\/j.cca.2020.07.032_b0100","first-page":"185","article-title":"Hypertension and chronic kidney disease","author":"Galleguillos","year":"2014","journal-title":"Adv. Hypertens. Res."},{"key":"10.1016\/j.cca.2020.07.032_b0105","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jfma.2018.02.007","article-title":"Update of pathophysiology and management of diabetic kidney disease","volume":"117","author":"Lin","year":"2018","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.cca.2020.07.032_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxlet.2017.11.032","article-title":"Role of arsenic exposure in adipose tissue dysfunction and its possible implication in diabetes pathophysiology","volume":"284","author":"Renu","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cca.2020.07.032_b0115","doi-asserted-by":"crossref","DOI":"10.1186\/s12882-018-0913-6","article-title":"The renal manifestations of type 4 familial partial lipodystrophy: A case report and review of literature","author":"Chen","year":"2018","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.cca.2020.07.032_b0120","doi-asserted-by":"crossref","DOI":"10.1210\/jc.2003-032140","article-title":"Proteinuric nephropathy in acquired and congenital generalized lipodystrophy: Baseline characteristics and course during recombinant leptin therapy","author":"Javor","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cca.2020.07.032_b0125","doi-asserted-by":"crossref","DOI":"10.2215\/CJN.05960616","article-title":"Focal segmental glomerulosclerosis","author":"Rosenberg","year":"2017","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cca.2020.07.032_b0130","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/719050","article-title":"Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth","author":"Rojas","year":"2014","journal-title":"Int. J. Reprod. Med."},{"key":"10.1016\/j.cca.2020.07.032_b0135","doi-asserted-by":"crossref","DOI":"10.1080\/19491034.2018.1509659","article-title":"Polycystic ovary syndrome in familial partial lipodystrophy type 2 (Fpld2): Basic and clinical aspects","author":"Gambineri","year":"2018","journal-title":"Nucleus."},{"key":"10.1016\/j.cca.2020.07.032_b0140","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/927805","article-title":"Leptin as well as free leptin receptor is associated with polycystic ovary syndrome in young women","author":"Rizk","year":"2015","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.cca.2020.07.032_b0145","author":"Progress","year":"2011","journal-title":"Focal Segmental Glomerulosclerosis"},{"key":"10.1016\/j.cca.2020.07.032_b0150","doi-asserted-by":"crossref","unstructured":"D. Pohlers, J. Brenmoehl, I. L\u00f6f, C.K. M\u00fcller, C. Leipner, S. Schultze-mosgau, A. Stallmach, R.W. Kinne, G. Wolf, Biochimica et Biophysica Acta TGF- \u03b2 and fi brosis in different organs \u2014 molecular pathway imprints, 1792 (2009) 746\u2013756. https:\/\/doi.org\/10.1016\/j.bbadis.2009.06.004.","DOI":"10.1016\/j.bbadis.2009.06.004"},{"key":"10.1016\/j.cca.2020.07.032_b0155","unstructured":"N. Raja-khan, M. Urbanek, R.J. Rodgers, R.S. Legro, Reproductive Sciences, (2014). https:\/\/doi.org\/10.1177\/1933719113485294."},{"key":"10.1016\/j.cca.2020.07.032_b0160","doi-asserted-by":"crossref","unstructured":"B.P. Section, U. States, C. Pathology, U. States, Thrombospondin-1 is a major activator of TGF- b in fibrotic renal disease in the rat in vivo, 65 (2004) 459\u2013468. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00395.x.","DOI":"10.1111\/j.1523-1755.2004.00395.x"},{"key":"10.1016\/j.cca.2020.07.032_b0165","doi-asserted-by":"crossref","unstructured":"T. Yamamoto, N.A. Noble, A.H. Cohen, C.C. Nast, A.M.I. Hishida, L.I. Gold, W.A. Border, Expression of transforming growth factor-n isoforms in human glomerular diseases, 49 (1996) 461\u2013469.","DOI":"10.1038\/ki.1996.65"},{"key":"10.1016\/j.cca.2020.07.032_b0170","doi-asserted-by":"crossref","unstructured":"N. Raja-Khan, M. Urbanek, R.J. Rodgers, R.S. Legro, The role of TGF-\u03b2 in polycystic ovary syndrome, Reprod. Sci. (2014). https:\/\/doi.org\/10.1177\/1933719113485294.","DOI":"10.1177\/1933719113485294"},{"key":"10.1016\/j.cca.2020.07.032_b0175","unstructured":"J.C. Adams, Evolution of Extracellular Matrix, 2013. https:\/\/doi.org\/10.1007\/978-3-642-36002-2."},{"key":"10.1016\/j.cca.2020.07.032_b0180","doi-asserted-by":"crossref","unstructured":"I.B. Robertson, M. Horiguchi, L. Zilberberg, B. Dabovic, D.B. Rifkin, HHS Public Access, (2016) 44\u201353. https:\/\/doi.org\/10.1016\/j.matbio.2015.05.005.Latent.","DOI":"10.1016\/j.matbio.2015.05.005"},{"key":"10.1016\/j.cca.2020.07.032_b0185","unstructured":"M. Hyyti\u00e4inen, C. Penttinen, J. Keski-oja, Critical Reviews in Clinical Laboratory Sciences Latent TGF- \u03b2 Binding Proteins\u00a0: Extracellular Matrix Association and Roles in TGF- \u03b2 Activation Latent TGF- \u03b2 Binding Proteins\u00a0: Extracellular Matrix Association and Roles in TGF- \u03b2 Activation, 8363 (2016). https:\/\/doi.org\/10.1080\/10408360490460933."},{"key":"10.1016\/j.cca.2020.07.032_b0190","doi-asserted-by":"crossref","unstructured":"J.P. Annes, J.S. Munger, D.B. Rifkin, Making sense of latent TGF \u03b2 activation, (2003). https:\/\/doi.org\/10.1242\/jcs.00229.","DOI":"10.1242\/jcs.00229"},{"key":"10.1016\/j.cca.2020.07.032_b0195","doi-asserted-by":"crossref","unstructured":"J.L. Wrana, L. Attisano, J. Carcamo, A. Zentella, M. Laiho, X.F. Wang, J. Massague, TGFp Signals through a Heteromeric Protein Kinase Receptor Complex, 71 (1992) 1003\u20131014.","DOI":"10.1016\/0092-8674(92)90395-S"},{"key":"10.1016\/j.cca.2020.07.032_b0200","doi-asserted-by":"crossref","unstructured":"P. Franzen, P. Dijke, H. Yamashita, P. Schulz, Cloning of a TGFp Type I Receptor That Forms a Heteromeric Complex with the TGFp Type II Receptor, 75 (1993).","DOI":"10.1016\/0092-8674(93)90489-D"},{"key":"10.1016\/j.cca.2020.07.032_b0205","doi-asserted-by":"crossref","unstructured":"T. Tsukazaki, T.A. Chiang, A.F. Davison, L. Attisano, J.L. Wrana, SARA , a FYVE Domain Protein that Recruits Smad2 to the TGF NL Receptor, 95 (1998) 779\u2013791.","DOI":"10.1016\/S0092-8674(00)81701-8"},{"key":"10.1016\/j.cca.2020.07.032_b0210","doi-asserted-by":"crossref","unstructured":"K.J. Gordon, G.C. Blobe, Role of transforming growth factor- \u03b2 superfamily signaling pathways in human disease, 1782 (2008) 197\u2013228. https:\/\/doi.org\/10.1016\/j.bbadis.2008.01.006.","DOI":"10.1016\/j.bbadis.2008.01.006"},{"key":"10.1016\/j.cca.2020.07.032_b0215","doi-asserted-by":"crossref","unstructured":"J. Prud, Pathobiology of transforming growth factor b in cancer , fibrosis and immunologic disease , and therapeutic considerations, 87 (2007) 1077\u20131091. https:\/\/doi.org\/10.1038\/labinvest.3700669.","DOI":"10.1038\/labinvest.3700669"},{"key":"10.1016\/j.cca.2020.07.032_b0220","doi-asserted-by":"crossref","unstructured":"K. Krieglstein, K. Miyazono, P. Dijke, K. Unsicker, TGF- \u03b2 in aging and disease, (2012) 5\u20139. https:\/\/doi.org\/10.1007\/s00441-011-1278-3.","DOI":"10.1007\/s00441-011-1278-3"},{"key":"10.1016\/j.cca.2020.07.032_b0225","doi-asserted-by":"crossref","unstructured":"A. Agrotis, N. Kalinina, A. Bobik, Transforming Growth Factor- \u03b2 , Cell Signaling and Cardiovascular Disorders, (2005) 55\u201361.","DOI":"10.2174\/1570161052773951"},{"key":"10.1016\/j.cca.2020.07.032_b0230","unstructured":"B. Li, A. Khanna, V. Sharma, T. Singh, M. Suthanthiran, P. August, TGF- NL 1 DNA Polymorphisms, Protein Levels, and Blood Pressure, 1 (1999)."},{"key":"10.1016\/j.cca.2020.07.032_b0235","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1038\/sj.ki.5001846","article-title":"Renal injury due to renin \u2013 angiotensin \u2013 aldosterone system activation of the transforming growth factor- b pathway","volume":"70","author":"Wolf","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2020.07.032_b0240","unstructured":"[17417899 - Reproduction] Pituitary actions of ligands of the TGF-\u03b2 family_ activins and inhibins.pdf, (n.d.)."},{"key":"10.1016\/j.cca.2020.07.032_b0245","doi-asserted-by":"crossref","unstructured":"J.T. Buijs, K.R. Stayrook, T.A. Guise, TGF- \u03b2 in the Bone Microenvironment\u00a0: Role in Breast Cancer Metastases, (2011) 261\u2013281. https:\/\/doi.org\/10.1007\/s12307-011-0075-6.","DOI":"10.1007\/s12307-011-0075-6"},{"key":"10.1016\/j.cca.2020.07.032_b0250","doi-asserted-by":"crossref","unstructured":"K. Aihara, Y. Ikeda, S. Yagi, M. Akaike, T. Matsumoto, Transforming Growth Factor- \u03b2 1 as a Common Target Molecule for Development of Cardiovascular Diseases , Renal Insufficiency and Metabolic Syndrome, 2011 (2011). https:\/\/doi.org\/10.4061\/2011\/175381.","DOI":"10.4061\/2011\/175381"},{"key":"10.1016\/j.cca.2020.07.032_b0255","doi-asserted-by":"crossref","unstructured":"A.G. Geiser, C.W. Hummel, M.W. Draper, J.W. Henck, I.R. Cohen, D.G. Rudmann, K.B. Donnelly, M.D. Adrian, T.A. Shepherd, O.B. Wallace, D.J. Mccann, S.W. Oldham, H.U. Bryant, M. Sato, J.A. Dodge, A New Selective Estrogen Receptor Modulator with Potent Uterine Antagonist Activity , Agonist Activity in Bone , and Minimal Ovarian Stimulation, 146 (2005) 4524\u20134535. https:\/\/doi.org\/10.1210\/en.2005-0024.","DOI":"10.1210\/en.2005-0024"},{"key":"10.1016\/j.cca.2020.07.032_b0260","article-title":"The emerging role of transforming growth factor-\u03b2 in kidney diseases","volume":"266","author":"Sharma","year":"1994","journal-title":"Am. J. Physiol. - Ren. Fluid Electrolyte Physiol."},{"key":"10.1016\/j.cca.2020.07.032_b0265","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S1357-2725(97)00128-3","article-title":"Molecules in focus Transforming growth factor-beta (TGF-\u03b2)","volume":"30","author":"Clark","year":"1998","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.cca.2020.07.032_b0270","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/S0270-9295(03)00132-3","article-title":"Diabetic Nephropathy and Transforming Growth Factor-\u03b2: Transforming Our View of Glomerulosclerosis and Fibrosis Build-Up","volume":"23","author":"Chen","year":"2003","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cca.2020.07.032_b0275","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0002-9440(10)64121-1","article-title":"Increased glomerular and tubular expression of transforming growth factor-\u03b21, its type II receptor, and activation of the smad signaling pathway in the db\/db mouse","volume":"158","author":"Hong","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cca.2020.07.032_b0280","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/ki.1993.95","article-title":"Renal interstitial expansion in insulin-dependent diabetes mellitus","volume":"43","author":"Lane","year":"1993","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2020.07.032_b0285","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0344-0338(80)80051-3","article-title":"Structure and Function of the Kidney in Diabetic Glomerulosclerosis: Correlations between Morphological and Functional Parameters","volume":"167","author":"Bader","year":"1980","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.cca.2020.07.032_b0290","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2337\/diab.45.4.522","article-title":"Neutralization of TGF-\u03b2 by anti-TGF-\u03b2 antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice","volume":"45","author":"Sharma","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2020.07.032_b0295","doi-asserted-by":"crossref","unstructured":"T.S. Suto, L.G. Fine, M. Kitamura, Mesangial cell-derived transforming growth factor-f31 reduces macrophage adhesiveness with consequent deactivation, 50 (1996) 445\u2013452. https:\/\/doi.org\/10.1038\/ki.1996.335.","DOI":"10.1038\/ki.1996.335"},{"key":"10.1016\/j.cca.2020.07.032_b0300","doi-asserted-by":"crossref","unstructured":"M.A. Kriegel, M.O. Li, S. Sanjabi, Y.Y. Wan, R.A. Flavell, Transforming Growth Factor- \u03b2\u00a0: Recent Advances on its Role in Immune Tolerance, (2006).","DOI":"10.1007\/s11926-006-0054-y"},{"key":"10.1016\/j.cca.2020.07.032_b0305","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1369\/jhc.2010.956615","article-title":"Fibrillins in Adult Human Ovary and Polycystic Ovary Syndrome : Is Fibrillin-3 Affected in PCOS ?","volume":"58","author":"Jordan","year":"2010","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.cca.2020.07.032_b0310","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.metabol.2013.05.003","article-title":"Follistatin and activins in polycystic ovary syndrome: Relationship to metabolic and hormonal markers","volume":"62","author":"Teede","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2020.07.032_b0315","doi-asserted-by":"crossref","first-page":"022034","DOI":"10.1088\/1757-899X\/263\/2\/022034","article-title":"To Screen Inactivation Mutation of Exon 1 of FSHR Gene in Polycystic Ovarian Syndrome: A South Indian Cohort Study","volume":"263","author":"Sekar","year":"2017","journal-title":"IOP Conf. Ser.: Mater. Sci. Eng."},{"key":"10.1016\/j.cca.2020.07.032_b0320","doi-asserted-by":"crossref","unstructured":"N. Sekar, M. Sapre, V. Kale, Y.D. Prabhu, K. Renu, S.S. Ramgir, V.G. Abilash, Inactivating Mutation screening of Exon 6 and Exon 10E of FSHR gene in women with Polycystic Ovarian Syndrome in Vellore population, in: IOP Conf. Ser. Mater. Sci. Eng., 2017. https:\/\/doi.org\/10.1088\/1757-899X\/263\/2\/022035.","DOI":"10.1088\/1757-899X\/263\/2\/022035"},{"key":"10.1016\/j.cca.2020.07.032_b0325","doi-asserted-by":"crossref","unstructured":"N. Sekar, R. Kulkarni, S. Ozalkar, Y.D. Prabhu, K. Renu, S.S. Ramgir, V.G. Abilash, Association of Exon 10A and 10B inactivating mutation of follicle stimulating hormone receptor gene (FSHR) and Polycystic Ovarian Syndrome in Vellore cohort, in: IOP Conf. Ser. Mater. Sci. Eng., 2017. https:\/\/doi.org\/10.1088\/1757-899X\/263\/2\/022036.","DOI":"10.1088\/1757-899X\/263\/2\/022036"},{"key":"10.1016\/j.cca.2020.07.032_b0330","doi-asserted-by":"crossref","unstructured":"M. Urbanek, S. Sam, R.S. Legro, A. Dunaif, Identification of a Polycystic Ovary Syndrome Susceptibility Variant in Fibrillin-3 and Association with a Metabolic Phenotype, 92 (2007) 4191\u20134198. https:\/\/doi.org\/10.1210\/jc.2007-0761.","DOI":"10.1210\/jc.2007-0761"},{"key":"10.1016\/j.cca.2020.07.032_b0335","doi-asserted-by":"crossref","unstructured":"C. Ponticelli, H. Anders, Thrombospondin immune regulation and the kidney, (2017) 995\u2013998. https:\/\/doi.org\/10.1093\/ndt\/gfw431.","DOI":"10.1093\/ndt\/gfw431"},{"key":"10.1016\/j.cca.2020.07.032_b0340","first-page":"30","article-title":"An update on \u201cprogression promoters\u201d in renal diseases","volume":"95","author":"Alebiosu","year":"2003","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.cca.2020.07.032_b0345","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00000441-200512000-00010","article-title":"Kidney disease and the metabolic syndrome","volume":"330","author":"Zhang","year":"2005","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.cca.2020.07.032_b0350","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.nephro.2010.11.007","article-title":"Renal consequences of obesity","volume":"7","author":"Laville","year":"2011","journal-title":"Nephrol. Ther."},{"key":"10.1016\/j.cca.2020.07.032_b0355","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.ackd.2006.07.012","article-title":"Epidemiology of Obesity and Chronic Kidney Disease","volume":"13","author":"Ross","year":"2006","journal-title":"Adv. Chronic Kidney Dis."},{"key":"10.1016\/j.cca.2020.07.032_b0360","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1046\/j.1523-1755.2001.0590041498.x","article-title":"Obesity-related glomerulopathy: An emerging epidemic","volume":"59","author":"Kambham","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.cca.2020.07.032_b0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TXD.0000000000000510","article-title":"Obesity Correlates With Glomerulomegaly But Is Not Associated With Kidney Dysfunction Early After Donation","volume":"1","author":"Chakkera","year":"2015","journal-title":"Transplant. Direct."},{"key":"10.1016\/j.cca.2020.07.032_b0370","unstructured":"M. Fessler, Michael B.; Rudel, Lawrence L.; Brown, \u57fa\u56e0\u7684\u6539\u53d8NIH Public Access, Bone. 23 (2008) 1\u20137. https:\/\/doi.org\/10.1038\/jid.2014.371."},{"key":"10.1016\/j.cca.2020.07.032_b0375","doi-asserted-by":"crossref","unstructured":"S.C. Tanguturi, S. Nagarakanti, Polycystic Ovary Syndrome and Periodontal disease\u00a0: Underlying Links- A Review, (2018). https:\/\/doi.org\/10.4103\/ijem.IJEM.","DOI":"10.4103\/ijem.IJEM_577_17"},{"key":"10.1016\/j.cca.2020.07.032_b0380","unstructured":"J.-M. M\u00e9rillon, K.G. Ramawat, eds., Bioactive Molecules in Food, Springer International Publishing, Cham, 2018. https:\/\/doi.org\/10.1007\/978-3-319-54528-8."},{"key":"10.1016\/j.cca.2020.07.032_b0385","doi-asserted-by":"crossref","unstructured":"B.M. Egan, Relationship between chronic kidney disease and metabolic syndrome\u00a0: current perspectives, (2014) 421\u2013435.","DOI":"10.2147\/DMSO.S45183"},{"key":"10.1016\/j.cca.2020.07.032_b0390","unstructured":"S. Jandeska, S.C. Hubchak, R.K. Basu, T. Hayashida, TGF-beta signal transduction in chronic kidney disease, (2009)."},{"key":"10.1016\/j.cca.2020.07.032_b0395","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1399-3046.2009.01261.x","article-title":"Recurrence of focal segmental glomerulosclerosis in renal allograft: An in-depth review","volume":"14","author":"Vinai","year":"2010","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.cca.2020.07.032_b0400","doi-asserted-by":"crossref","unstructured":"G. Injury, G. Hypertension, C. Baylis, W. Virginia, C. Baylis, Age-dependent Glomerular Damage in the Rat, 94 (1994) 1823\u20131829.","DOI":"10.1172\/JCI117531"},{"key":"10.1016\/j.cca.2020.07.032_b0405","first-page":"S46","article-title":"CKD Surveillance Using Laboratory Data From the Population-Based National Health and Nutrition Examination Survey (NHANES)","volume":"53","author":"Castro","year":"2009","journal-title":"YAJKD"},{"key":"10.1016\/j.cca.2020.07.032_b0410","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1530\/eje.0.1460789","article-title":"Agonistic and antagonistic properties of progesterone metabolites at the human mineralocorticoid receptor","volume":"146","author":"Quinkler","year":"2002","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.cca.2020.07.032_b0415","doi-asserted-by":"crossref","unstructured":"A. Organ, W. Oelkers, S. Diederich, K.B. Franklin, The Human Kidney Is a Progesterone-Metabolizing and, 88 (2003) 2803\u20132809. https:\/\/doi.org\/10.1210\/jc.2002-021970.","DOI":"10.1210\/jc.2002-021970"},{"key":"10.1016\/j.cca.2020.07.032_b0420","doi-asserted-by":"crossref","unstructured":"A. Quan, S. Chakravarty, J. Chen, J. Chen, S. Loleh, N. Saini, R.C. Harris, J. Capdevila, R. Quigley, S. Chakravarty, J. Chen, C. Chen, S. Loleh, N. Saini, R.C. Harris, R. Quigley, Androgens augment proximal tubule transport, 9063 (2020) 452\u2013459.","DOI":"10.1152\/ajprenal.00188.2003"},{"key":"10.1016\/j.cca.2020.07.032_b0425","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic Ovary Syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cca.2020.07.032_b0430","unstructured":"S. Sadrefozalayi, F. Farokhi, Effect of the aqueous extract of Foeniculum vulgare (fennel) on the kidney in experimental PCOS female rats., Avicenna J. Phytomedicine. 4 (2014) 110\u20137. https:\/\/doi.org\/10.22038\/ajp.2014.1824."},{"key":"10.1016\/j.cca.2020.07.032_b0435","first-page":"169","article-title":"Early onset of proteinuria and focal segmental glomerulosclerosis in obese, hyperinsulinemic adolescents developing metabolic syndrome, Diabetes Metab. Syndr. Clin","volume":"3","author":"Newfield","year":"2009","journal-title":"Res. Rev."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120303569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898120303569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:57:03Z","timestamp":1757861823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898120303569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":87,"alternative-id":["S0009898120303569"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2020.07.032","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of TGF-\u03b2 signalling in PCOS associated focal segmental glomerulosclerosis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2020.07.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}